Confirmed speakers:
- Prof. Dr. Barbara Burwinkel
Head of Molecular Epidemiology Department, German Cancer Research Center (DKFZ), Heidelberg, Germany - Prof. Dr. Oliver Fiehn
Director, NIH West Coast Metabolomics Center, University of California, Davis, USA - Prof. Dr. Carsten Grüllich
Head of Translational Uro-Oncology Department, National Center for Tumor Diseases, Heidelberg, Germany - Prof. Dr. Stephan Herzig
Director, Institute for Diabetes and Cancer, Helmholtz Zentrum München, Munich, Germany - Prof. Dr. Karsten Hiller
Head of Department of Bioinformatics and Biochemistry, Technical University Braunschweig, Germany - Prof. Dr. Carsten Hopf
Director of Center for Biomedical Mass Spectrometry and Optical Spectroscopy, University Medical Centre Mannheim, Mannheim, Germany - Prof. Dr. Hector Keun
Head of Cancer Metabolism and Systems Toxicology Group, Imperial College London, UK - Dr. Therese Koal
Director, Research and Development, Biocrates Life Sciences AG, Innsbruck, Austria - Dr. Augustin Scalbert
Head of Biomarkers Group, International Agency for Research on Cancer (WHO), Lyon, France - Prof. Dr. Almut Schulze
Head of Department of Biochemistry and Molecular Biology, University of Würzburg, Germany - Prof. Dr. Aurelio Teleman
Head of Signal Transduction in Cancer and Metabolism Department, German Cancer Research Center (DKFZ), Heidelberg, Germany